| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/22/2023 | -16.02% | JP Morgan | $23 → $28 | Maintains | Underweight |
| 08/14/2023 | -43.01% | Mizuho | $16 → $19 | Maintains | Underperform |
| 08/14/2023 | -7.02% | Barclays | $17 → $31 | Maintains | Equal-Weight |
| 08/09/2023 | 4.98% | Piper Sandler | $17 → $35 | Maintains | Neutral |
| 08/08/2023 | -31.01% | JP Morgan | $11 → $23 | Maintains | Underweight |
| 07/27/2023 | 46.97% | B. Riley Securities | → $49 | Initiates Coverage On | → Neutral |
| 07/26/2023 | -82% | Stephens & Co. | → $6 | Reiterates | Underweight → Underweight |
| 07/25/2023 | 115.96% | BTIG | $42 → $72 | Maintains | Buy |
| 06/28/2023 | -82% | Stephens & Co. | → $6 | Reiterates | Underweight → Underweight |
| 06/14/2023 | -52.01% | Mizuho | → $16 | Reiterates | Underperform → Underperform |
| 06/14/2023 | 25.97% | BTIG | → $42 | Initiates Coverage On | → Buy |
| 05/23/2023 | -76% | Compass Point | $6 → $8 | Maintains | Sell |
| 05/18/2023 | -82% | Stephens & Co. | → $6 | Reiterates | Underweight → Underweight |
| 05/11/2023 | -55.01% | Citigroup | $11 → $15 | Maintains | Sell |
| 05/10/2023 | -70.01% | Wedbush | → $10 | Reiterates | → Underperform |
| 05/10/2023 | -61.01% | Morgan Stanley | $10 → $13 | Maintains | Underweight |
| 05/10/2023 | -52.01% | Mizuho | $14 → $16 | Maintains | Underperform |
| 05/10/2023 | -49.01% | Piper Sandler | $16 → $17 | Maintains | Neutral |
| 05/05/2023 | -70.01% | Morgan Stanley | $11 → $10 | Maintains | Underweight |
| 04/11/2023 | -67.01% | JP Morgan | → $11 | Initiates Coverage On | → Underweight |
| 03/07/2023 | -82% | Compass Point | → $6 | Initiates Coverage On | → Sell |
| 02/21/2023 | -58.01% | Mizuho | $16 → $14 | Maintains | Underperform |
| 02/15/2023 | -67.01% | Citigroup | $17 → $11 | Downgrades | Neutral → Sell |
| 02/15/2023 | -52.01% | Piper Sandler | → $16 | Reiterates | → Neutral |
| 02/08/2023 | -67.01% | Morgan Stanley | $11.5 → $11 | Maintains | Underweight |
| 02/03/2023 | -28.01% | Loop Capital | → $24 | Downgrades | Buy → Hold |
| 02/01/2023 | -52.01% | Mizuho | $14 → $16 | Maintains | Underperform |
| 01/20/2023 | -49.01% | Citigroup | $33 → $17 | Maintains | Neutral |
| 01/18/2023 | -52.01% | Piper Sandler | $14 → $16 | Maintains | Neutral |
| 12/12/2022 | -58.01% | Mizuho | $12 → $14 | Maintains | Underperform |
| 11/10/2022 | -55.01% | B of A Securities | → $15 | Downgrades | Neutral → Underperform |
| 11/09/2022 | -64.01% | Stephens & Co. | $23 → $12 | Maintains | Underweight |
| 11/09/2022 | -67.01% | Goldman Sachs | $14 → $11 | Maintains | Sell |
| 11/09/2022 | -65.51% | Morgan Stanley | $15 → $11.5 | Maintains | Underweight |
| 11/09/2022 | -64.01% | Mizuho | $17 → $12 | Maintains | Underperform |
| 11/09/2022 | -58.01% | Piper Sandler | $24 → $14 | Maintains | Neutral |
| 10/25/2022 | -49.01% | Mizuho | → $17 | Initiates Coverage On | → Underperform |
| 08/15/2022 | 10.98% | Barclays | $25 → $37 | Maintains | Equal-Weight |
| 08/11/2022 | -34.01% | Atlantic Equities | $32 → $22 | Downgrades | Neutral → Underweight |
| 08/09/2022 | -55.01% | Morgan Stanley | $15.5 → $15 | Maintains | Underweight |
| 08/09/2022 | -31.01% | Stephens & Co. | $28 → $23 | Maintains | Underweight |
| 08/09/2022 | -28.01% | Piper Sandler | $25 → $24 | Maintains | Neutral |
| 07/18/2022 | -25.01% | Piper Sandler | $44 → $25 | Maintains | Neutral |
| 07/18/2022 | -25.01% | Barclays | $35 → $25 | Maintains | Equal-Weight |
| 07/15/2022 | -53.51% | Morgan Stanley | $19 → $15.5 | Maintains | Underweight |
| 07/11/2022 | -58.01% | Goldman Sachs | $40 → $14 | Downgrades | Neutral → Sell |
| 07/08/2022 | 1.98% | B of A Securities | $41 → $34 | Maintains | Neutral |
| 07/08/2022 | — | JMP Securities | Downgrades | Market Outperform → Market Perform | |
| 06/29/2022 | -43.01% | Morgan Stanley | $88 → $19 | Downgrades | Equal-Weight → Underweight |
| 05/13/2022 | -40.01% | Wedbush | $35 → $20 | Maintains | Underperform |
| 05/12/2022 | 4.98% | Barclays | $180 → $35 | Downgrades | Overweight → Equal-Weight |
| 05/11/2022 | 4.98% | Barclays | → $35 | Downgrades | Overweight → Equal-Weight |
| 05/11/2022 | 34.97% | Atlantic Equities | $245 → $45 | Downgrades | Overweight → Neutral |
| 05/11/2022 | 22.98% | B of A Securities | $255 → $41 | Downgrades | Buy → Neutral |
| 05/10/2022 | 19.98% | Goldman Sachs | $250 → $40 | Downgrades | Buy → Neutral |
| 05/10/2022 | 109.96% | JMP Securities | $245 → $70 | Maintains | Market Outperform |
| 05/10/2022 | 4.98% | Wedbush | $70 → $35 | Maintains | Underperform |
| 05/10/2022 | 49.97% | Citigroup | $180 → $50 | Downgrades | Buy → Neutral |
| 05/10/2022 | -16.02% | Stephens & Co. | $124 → $28 | Downgrades | Equal-Weight → Underweight |
| 05/10/2022 | 31.97% | Piper Sandler | $230 → $44 | Downgrades | Overweight → Neutral |
| 05/04/2022 | 163.95% | Morgan Stanley | $115 → $88 | Maintains | Equal-Weight |
| 04/22/2022 | 439.89% | Citigroup | $350 → $180 | Maintains | Buy |
| 04/12/2022 | 349.91% | FBN Securities | → $150 | Initiates Coverage On | → Outperform |
| 04/06/2022 | 319.92% | Loop Capital | → $140 | Initiates Coverage On | → Buy |
| 04/01/2022 | 271.93% | Stephens & Co. | → $124 | Initiates Coverage On | → Equal-Weight |
| 03/22/2022 | 124.96% | Wedbush | $110 → $75 | Downgrades | Neutral → Underperform |
| 02/17/2022 | 664.85% | B of A Securities | → $255 | Upgrades | Underperform → Buy |
| 02/16/2022 | 634.85% | JMP Securities | $315 → $245 | Maintains | Market Outperform |
| 02/16/2022 | 589.86% | Piper Sandler | $223 → $230 | Maintains | Overweight |
| 01/13/2022 | 568.87% | Piper Sandler | $300 → $223 | Maintains | Overweight |
| 12/22/2021 | 379.9% | Wedbush | → $160 | Initiates Coverage On | → Neutral |
| 12/09/2021 | 499.88% | Morgan Stanley | → $200 | Initiates Coverage On | → Equal-Weight |
| 11/15/2021 | 844.81% | JMP Securities | $327 → $315 | Maintains | Market Outperform |
| 10/26/2021 | — | Jefferies | Downgrades | Buy → Hold | |
| 10/18/2021 | 799.82% | B of A Securities | → $300 | Downgrades | Neutral → Underperform |
| 09/20/2021 | 934.79% | Barclays | $230 → $345 | Maintains | Overweight |
| 09/17/2021 | 880.8% | JMP Securities | $205 → $327 | Maintains | Market Outperform |
| 09/08/2021 | 799.82% | Piper Sandler | $192 → $300 | Maintains | Overweight |
| 08/13/2021 | 589.86% | Barclays | $130 → $230 | Upgrades | Equal-Weight → Overweight |
| 08/11/2021 | 472.89% | Piper Sandler | $152 → $191 | Maintains | Overweight |
| 08/11/2021 | 514.88% | Citigroup | $120 → $205 | Upgrades | Neutral → Buy |
| 07/12/2021 | 340.91% | Goldman Sachs | → $147 | Initiates Coverage On | → Buy |
| 06/07/2021 | 469.89% | JMP Securities | $149 → $190 | Maintains | Market Outperform |
| 05/12/2021 | 346.91% | JMP Securities | $111 → $149 | Maintains | Market Outperform |
| 04/27/2021 | 328.91% | Piper Sandler | → $143 | Initiates Coverage On | → Overweight |
| 03/22/2021 | 229.93% | Barclays | $58 → $110 | Maintains | Equal-Weight |
| 03/18/2021 | 232.93% | JMP Securities | → $111 | Upgrades | Market Perform → Market Outperform |
| 01/11/2021 | 70.97% | B of A Securities | → $57 | Initiates Coverage On | → Neutral |
| 01/11/2021 | 97.96% | Jefferies | → $66 | Initiates Coverage On | → Buy |
| 01/11/2021 | 73.97% | Barclays | → $58 | Initiates Coverage On | → Equal-Weight |
| 01/11/2021 | — | JMP Securities | Initiates Coverage On | → Market Perform | |
| 01/11/2021 | 64.97% | Goldman Sachs | → $55 | Initiates Coverage On | → Neutral |
What is the target price for Upstart Hldgs (UPST)?
The latest price target for Upstart Hldgs (NASDAQ: UPST) was reported by JP Morgan on August 22, 2023. The analyst firm set a price target for $28.00 expecting UPST to fall to within 12 months (a possible -16.02% downside). 37 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Upstart Hldgs (UPST)?
The latest analyst rating for Upstart Hldgs (NASDAQ: UPST) was provided by JP Morgan, and Upstart Hldgs maintained their underweight rating.
When is the next analyst rating going to be posted or updated for Upstart Hldgs (UPST)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Upstart Hldgs, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Upstart Hldgs was filed on August 22, 2023 so you should expect the next rating to be made available sometime around August 22, 2024.
Is the Analyst Rating Upstart Hldgs (UPST) correct?
While ratings are subjective and will change, the latest Upstart Hldgs (UPST) rating was a maintained with a price target of $23.00 to $28.00. The current price Upstart Hldgs (UPST) is trading at is $33.34, which is out of the analyst's predicted range.